Aquestive Therapeutics Files 2024 10-K
Ticker: AQST · Form: 10-K · Filed: Mar 5, 2025 · CIK: 1398733
| Field | Detail |
|---|---|
| Company | Aquestive Therapeutics, Inc. (AQST) |
| Form Type | 10-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Aquestive Therapeutics filed its 2024 10-K. Financials are in.
AI Summary
Aquestive Therapeutics, Inc. filed its 2024 10-K on March 5, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as MonoSol Rx, Inc., is based in Warren, NJ. Key financial details and business operations for the period are outlined in the filing.
Why It Matters
This filing provides a comprehensive overview of Aquestive Therapeutics' financial health and operational performance for the fiscal year 2024, crucial for investors and stakeholders to assess the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Aquestive Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their 10-K filing.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 135 — Document Count (Number of documents in the filing)
Key Players & Entities
- Aquestive Therapeutics, Inc. (company) — Filer of the 10-K
- MonoSol Rx, Inc. (company) — Former name of Aquestive Therapeutics
- 2024-12-31 (date) — Fiscal year end
- 2025-03-05 (date) — Filing date
- Warren, NJ (location) — Company business address
FAQ
What was Aquestive Therapeutics' former name?
Aquestive Therapeutics, Inc. was formerly known as MonoSol Rx, Inc., with a date of name change on 20070507.
When did Aquestive Therapeutics file its 2024 10-K?
Aquestive Therapeutics filed its 2024 10-K on March 5, 2025.
What is the fiscal year end for Aquestive Therapeutics?
The fiscal year end for Aquestive Therapeutics is December 31.
Where is Aquestive Therapeutics located?
Aquestive Therapeutics' business address is 30 Technology Drive, Warren, NJ 07059.
What is the SIC code for Aquestive Therapeutics?
The Standard Industrial Classification (SIC) code for Aquestive Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 5, 2025 regarding Aquestive Therapeutics, Inc. (AQST).